期刊文献+

他汀类药物联用依那普利治疗原发性高血压的临床观察 被引量:10

下载PDF
导出
摘要 目的:观察他汀类药物与依那普利联用治疗原发性高血压的疗效。方法:128例高血压患者随机分为治疗组和对照组,治疗组65例,采用辛伐他汀联用依那普利;对照组63例,单用依那普利,疗程均为3个月。结果:治疗组降压有效率92.31%,对照组有效率80.95%,两组比较P<0.05;治疗后治疗组血总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)水平、收缩压(SBP)、舒张压(DBP)变化情况均优于对照组(P<0.05)。结论:他汀类药物联合依那普利治疗原发性高血压疗效肯定,值得临床推广使用。
作者 马海珍
出处 《医学理论与实践》 2011年第3期278-279,共2页 The Journal of Medical Theory and Practice
  • 相关文献

参考文献5

二级参考文献63

  • 1谢良地,杨月榕,吴欣,陈玲,孙明.氟伐他汀对高血压患者阻力血管功能的影响[J].福建医科大学学报,2002,36(S1). 被引量:1
  • 2曾群英 张育君.辛伐他汀(舒降之)治疗冠心病高胆固醇血症的临床研究[J].新医学,1998,29(1):11-13.
  • 3[1]Carlson LA, Rosenhamer G. Reduction in mortlity in Stockholm Ischemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand, 1988;223:405~418
  • 4[2]Buchwald H, Matts JP, Fitch LL, et al. for the Program on the Surgical Control of Hyperlipidemias (POSCH)Group: Changes in sequential coranary arteriograms and subsequent coronary events. JAMA,1992;268:1429
  • 5[3]Scandinavian Simvastatin Survival Study(4S) Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease.Lancet, 1994; 344:1383~ 1389
  • 6[4]Sacks FM, Pfeffer MA, Moye LA,et al. for the Cholesterol And Recurrent Events Trial(CARE). The effect of pravastatin on coronaryevents after myocardial infarction in patients with average cholesterol levels. N Engl J Med, 1996; 335:1001~1009
  • 7[5]National Cholesterol Education Program: Second report of the expert on detection, evaluation, and treatment of high blood cholesterol in adult. Circulation, 1994;89:1329
  • 8[6]The Long Term Investigation With Pravastatin In Ischaemic Disease (LIPID)Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998; 339:1349~1357
  • 9[7]Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary disease in men with hypercholesterolemia. West of Scotland Coronary Prevention Study (WOSCOPS) Group. N Engl J Med, 1995; 333:1301~1307
  • 10[8]Down JR, Clearfield M, Weis S, et al. for the AFCAPS/TexCAPS Research Group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. JAMA,1998;279:1615~1622

共引文献110

同被引文献46

  • 1尹学亮,李建柱,梁添书,张启确,曾文坦.辛伐他汀对原发性高血压患者血、尿β_2-微球蛋白的影响[J].临床内科杂志,2007,24(1):52-53. 被引量:9
  • 2Jantzen F, Nemann S, Wolff B, et al. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and incereases NO synthase activity in human um- bilical vein endothelial cells [ J ]. Journal of Physiol and Pharmacol, 2007,58 ( 3 ) :503 - 514.
  • 3Tycinska AM, Janica J, Mroczko B, et al. I-Iypotensive effect of atorv- astatin in hypertensive patients:the association among flow-m func- tion[J]. Arch Med Sci,2011,7(6) :955 -962.
  • 4Kuklinska AM, Mroczko B, Musial WJ, et al. Influence of atorvasta- tin on blood pressure control in treated hypertensive, normolipemic patients - An open, pilot study [ J ]. Blood Press, 2010,19 ( 4 ) : 260 - 266.
  • 5Ruperez M, Rodrigues-Diez R, Blanco-Colio LM, et ah HMG CoA re- ductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways[ J ]. Hypertension ,2007, 50(2) :377 -383.
  • 6Dumont AS, Hyndman ME, Dumont RJ,, et aL Improvement of endo- thelial function in insulin-resistant carotid arteries treated with pravastatin [ J ]. J Neurosurg,2001,95 (3) :466 - 471.
  • 7Jiang J, Roman RJ. Lovastatin prevents development of hypertension in spontaneously hypertensive rats [ J ]. Hypertension, 1997,30 ( 4 ) : 968 - 974.
  • 8Welten GM,Chonchol M,Schouten O,et al. Statin use is associated with early recovery of kidney injury after vascular surgery and im-proved long-term outcome [ J ]. Nephrol Dial Transplant, 2008,23 (12) :3867 -3873.
  • 9Kanaki AI, Sarafidis PA, Georgianos PI, et al. Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia : a double-blind, randomized, placebo-con- trolled study[ J]. J Hum Hypertens,2012,26(10) :577 - 584.
  • 10Li X, Yang G, Zhao G, et al. Rosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive pro- tein [ J ]. Hypertens Res,2011,34 (7) :869 - 875.

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部